Ziv-aflibercept Efficacy in Better Regulating AMD

Summary

This is a randomized, open-label, interventional, controlled study to determine the effects of Zaltrap on Neovascularized Wet Macular Degeneration as compared to the control anti-vascular endothelial growth factor ("anti-VEGF") injections (bevacizumab, ranibizumab, or aflibercept).

Timeline

Start

2017-07-07

Primary completion

2020-06-26

Completion

2020-06-26

Drugs

Indications